| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3268684 | HPB | 2016 | 8 Pages |
Abstract
Although total pancreatectomy is a reasonable option for selected patients with pancreatic ductal adenocarcinoma, survival of the entire group is limited. Operative mortality is improved from prior reports. Greater survival benefits were seen in younger patients with smaller, node negative tumors resected with negative margins in academic research centers.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
W. Cory Johnston, Helena M. Hoen, Maria A. Cassera, Pippa H. Newell, Chet W. Hammill, Paul D. Hansen, Ronald F. Wolf,